Finwise is pleased that PIPRA, a Swiss medtech company we worked with this year has been recognised as one of the most promising early-stage Health Ventures 2022 across the globe.
Home » Pipra recognised as one of the most promising early-stage HealthTech Ventures 2022
Pipra recognised as one of the most promising early-stage HealthTech Ventures 2022
